{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:40:24Z","timestamp":1756363224728,"version":"3.44.0"},"reference-count":46,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p>Radioiodine (I), a radioactive isotope of iodine, is widely used for the treatment of patients with thyroid disorders, particularly hyperthyroidism. Its use in hyperthyroidism has increased in the UK since we last reviewed this subject1 (e.g. from a total of 8,000 doses in 1982 to 10,000 in 2003\/42). Here we reconsider the use of radioactive iodine in adults with hyperthyroidism, including how it compares with antithyroid drugs and surgery, the other therapies for hyperthyroidism.<\/jats:p>","DOI":"10.1136\/dtb.2006.44644","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"44-48","source":"Crossref","is-referenced-by-count":2,"title":["Radioiodine therapy for hyperthyroidism"],"prefix":"10.1136","volume":"44","member":"239","published-online":{"date-parts":[[2006,6,1]]},"reference":[{"key":"2025082723120624000_44.6.44.1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/dtb.31.10.39","article-title":"Radioiodine for the treatment of thyroid disease","volume":"31","year":"1993","journal-title":"DTB"},{"key":"2025082723120624000_44.6.44.2","unstructured":"Hart D Wall BF . A survey of nuclear medicine in the UK in 2003\/4. Health Protection Agency, 2005 [online] http:\/\/www.hpa.org.uk\/radiation\/publications\/hpa_rpd_reports\/2005\/hpa_rpd_003.htm [Accessed 4 May 2006]."},{"key":"2025082723120624000_44.6.44.3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025082723120624000_44.6.44.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01340.x"},{"key":"2025082723120624000_44.6.44.5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM199406163302407","article-title":"The management of hyperthyroidism","volume":"330","author":"Franklyn","year":"1994","journal-title":"N Engl J Med"},{"key":"2025082723120624000_44.6.44.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406163302407"},{"key":"2025082723120624000_44.6.44.7","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016476"},{"key":"2025082723120624000_44.6.44.8","unstructured":"Department of Health. 2005 The Administration of Radioactive Substances Advisory Committee (ARSAC) [Online] http:\/\/www.advisorybodies.doh.gov.uk\/arsac\/index.htm [Accessed 2 May 2006]."},{"key":"2025082723120624000_44.6.44.9","unstructured":"Radiation protection 97. Radiation protection following iodine-131 therapy (exposures due to out-patients or discharged in-patients) [Online] http:\/\/europa.eu.int\/comm\/energy\/nuclear\/radioprotection\/publication\/doc\/097_en.pdf [Accessed 2 May 2006]."},{"key":"2025082723120624000_44.6.44.10","first-page":"186","article-title":"Radioiodine therapy of Graves' hyperthyroidism: a standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study","volume-title":"Eur J Clin Invest","volume":"25","author":"Peters","year":"1995"},{"key":"2025082723120624000_44.6.44.11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1995.tb02039.x","article-title":"Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile?","volume":"43","author":"Jarl\u00f8v","year":"1995","journal-title":"Clin Endocrinol"},{"key":"2025082723120624000_44.6.44.12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","article-title":"A randomized comparison of radioiodine doses in Graves' hyperthyroidism","volume":"88","author":"Leslie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082723120624000_44.6.44.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020805"},{"key":"2025082723120624000_44.6.44.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.8.3611"},{"key":"2025082723120624000_44.6.44.15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2265.2004.02152.x","article-title":"Long-term follow-up study of radioiodine treatment of hyperthyroidism","volume":"61","author":"Metso","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025082723120624000_44.6.44.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02152.x"},{"key":"2025082723120624000_44.6.44.17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1991.tb01738.x","article-title":"Long-term follow-up of treatment of thyrotoxicosis by three different methods","volume":"34","author":"Franklyn","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025082723120624000_44.6.44.18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.294.1.71","article-title":"Thyroid function and mortality in patients treated for hyperthyroidism","volume":"294","author":"Franklyn","year":"2005","journal-title":"JAMA"},{"key":"2025082723120624000_44.6.44.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.71"},{"key":"2025082723120624000_44.6.44.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6441.361"},{"key":"2025082723120624000_44.6.44.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02218.x"},{"key":"2025082723120624000_44.6.44.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.4.1229"},{"key":"2025082723120624000_44.6.44.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0247"},{"key":"2025082723120624000_44.6.44.24","unstructured":"Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources [Online] http:\/\/www.arsac.org.uk\/notes_for_guidence\/docs\/arsac_nfg.pdf [Accessed 4 May 2006]."},{"key":"2025082723120624000_44.6.44.25","first-page":"3767","article-title":"The management of Graves' disease in children, with special emphasis on radioiodine treatment","volume":"83","author":"Rivkees","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082723120624000_44.6.44.26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.11.3767"},{"key":"2025082723120624000_44.6.44.27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031223"},{"key":"2025082723120624000_44.6.44.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2003.09.004"},{"key":"2025082723120624000_44.6.44.29","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"2025082723120624000_44.6.44.30","unstructured":"Royal College of Physicians of London. Guidelines: The use of radioiodine in the management of benign thyroid disorders 2006 [in preparation]."},{"key":"2025082723120624000_44.6.44.31","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082723120624000_44.6.44.32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0507"},{"key":"2025082723120624000_44.6.44.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801083380201"},{"key":"2025082723120624000_44.6.44.34","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91217-2"},{"key":"2025082723120624000_44.6.44.35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01329.x"},{"key":"2025082723120624000_44.6.44.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.4.347"},{"key":"2025082723120624000_44.6.44.37","unstructured":"Institute of Physics and Engineering in Medicine. Medical and Dental Guidance Notes A good practice guide on all aspects of ionising radiation protection in the clinical environment York: IPEM 2000."},{"key":"2025082723120624000_44.6.44.38","unstructured":"Abraham P . Antithyroid drug regimen for treating Graves' hyperthyroidism The Cochrane Database of Systematic Reviews."},{"key":"2025082723120624000_44.6.44.39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin Endcrinol (Oxf)"},{"key":"2025082723120624000_44.6.44.40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00843.x","article-title":"The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study","volume":"51","author":"Marcocci","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025082723120624000_44.6.44.41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00843.x"},{"key":"2025082723120624000_44.6.44.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2005.03441.x"},{"key":"2025082723120624000_44.6.44.43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00405-002-0455-0","article-title":"Multinodular goiter: surgical management and histopathological findings","volume":"259","author":"Prades","year":"2002","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025082723120624000_44.6.44.44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/eje.1.01904","article-title":"Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine","volume":"152","author":"Azizi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2025082723120624000_44.6.44.45","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01904"},{"key":"2025082723120624000_44.6.44.46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.8.2986"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2006.44644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:12:16Z","timestamp":1756361536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2006.44644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,6,1]]},"published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1136\/dtb.2006.44644"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2006.44644","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}